These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23045655)

  • 1. Pharmacological chaperones for human α-N-acetylgalactosaminidase.
    Clark NE; Metcalf MC; Best D; Fleet GW; Garman SC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17400-5. PubMed ID: 23045655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1.9 a structure of human alpha-N-acetylgalactosaminidase: The molecular basis of Schindler and Kanzaki diseases.
    Clark NE; Garman SC
    J Mol Biol; 2009 Oct; 393(2):435-47. PubMed ID: 19683538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability.
    Lieberman RL; D'aquino JA; Ringe D; Petsko GA
    Biochemistry; 2009 Jun; 48(22):4816-27. PubMed ID: 19374450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases.
    Tomasic IB; Metcalf MC; Guce AI; Clark NE; Garman SC
    J Biol Chem; 2010 Jul; 285(28):21560-6. PubMed ID: 20444686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and immunocytochemical studies on alpha-N-acetylgalactosaminidase deficiency (Schindler/Kanzaki disease).
    Sakuraba H; Matsuzawa F; Aikawa SI; Doi H; Kotani M; Nakada H; Fukushige T; Kanzaki T
    J Hum Genet; 2004; 49(1):1-8. PubMed ID: 14685826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1.9 A structure of alpha-N-acetylgalactosaminidase: molecular basis of glycosidase deficiency diseases.
    Garman SC; Hannick L; Zhu A; Garboczi DN
    Structure; 2002 Mar; 10(3):425-34. PubMed ID: 12005440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and Selective Cell-Active Iminosugar Inhibitors of Human α-N-Acetylgalactosaminidase (α-NAGAL).
    Ashmus RA; Wang Y; González-Cuesta M; King DT; Tiet B; Chen X; Zhu Y; Kirk B; García Fernandez JM; Ortiz Mellet C; Britton R; Vocadlo DJ
    Chemistry; 2023 Aug; 29(44):e202300982. PubMed ID: 37217457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni α-N-acetylgalactosaminidase (SmNAGAL) regulates coordinated parasite movement and egg production.
    Hulme BJ; Geyer KK; Forde-Thomas JE; Padalino G; Phillips DW; Ittiprasert W; Karinshak SE; Mann VH; Chalmers IW; Brindley PJ; Hokke CH; Hoffmann KF
    PLoS Pathog; 2022 Jan; 18(1):e1009828. PubMed ID: 35025955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low α-N-acetylgalactosaminidase plasma concentration correlates with the presence and severity of the bipolar affective disorder.
    Yilmaz S; Öner P
    World J Biol Psychiatry; 2023 Feb; 24(2):187-194. PubMed ID: 36102137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could low α-N-acetylgalactosaminidase plasma concentration cause schizophrenia?
    Yılmaz S; Öner P
    World J Biol Psychiatry; 2023 Jan; 24(1):70-77. PubMed ID: 35521802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Schindler disease/Kanzaki disease [alpha-N-acetylgalactosaminidase deficiency]].
    Kanzaki T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):372-4. PubMed ID: 9645085
    [No Abstract]   [Full Text] [Related]  

  • 12. The molecular basis of pharmacological chaperoning in human α-galactosidase.
    Guce AI; Clark NE; Rogich JJ; Garman SC
    Chem Biol; 2011 Dec; 18(12):1521-6. PubMed ID: 22195554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, purification, and characterization of recombinant alpha-N-acetylgalactosaminidase produced in the yeast Pichia pastoris.
    Zhu A; Monahan C; Wang ZK; Goldstein J
    Protein Expr Purif; 1996 Dec; 8(4):456-62. PubMed ID: 8954893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines.
    Benjamin ER; Flanagan JJ; Schilling A; Chang HH; Agarwal L; Katz E; Wu X; Pine C; Wustman B; Desnick RJ; Lockhart DJ; Valenzano KJ
    J Inherit Metab Dis; 2009 Jun; 32(3):424-40. PubMed ID: 19387866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of an α-N-acetylgalactosaminidase from Clonorchis sinensis.
    Lee MR; Yoo WG; Kim YJ; Kim DW; Cho SH; Hwang KY; Ju JW; Lee WJ
    Parasitol Res; 2012 Nov; 111(5):2149-56. PubMed ID: 22926676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants.
    Yam GH; Bosshard N; Zuber C; Steinmann B; Roth J
    Am J Physiol Cell Physiol; 2006 Apr; 290(4):C1076-82. PubMed ID: 16531566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational and modeling approaches to understand the impact of the Fabry's disease causing mutation (D92Y) on the interaction with pharmacological chaperone 1-deoxygalactonojirimycin (DGJ).
    Thirumal Kumar D; Judith E; Priyadharshini Christy J; Siva R; Tayubi IA; Chakraborty C; George Priya Doss C; Zayed H
    Adv Protein Chem Struct Biol; 2019; 114():341-407. PubMed ID: 30635085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate and Substrate-Mimetic Chaperone Binding Sites in Human α-Galactosidase A Revealed by Affinity-Mass Spectrometry.
    Moise A; Maeser S; Rawer S; Eggers F; Murphy M; Bornheim J; Przybylski M
    J Am Soc Mass Spectrom; 2016 Jun; 27(6):1071-8. PubMed ID: 27112153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new case of alpha-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Ménière's syndrome and without mental retardation.
    Kodama K; Kobayashi H; Abe R; Ohkawara A; Yoshii N; Yotsumoto S; Fukushige T; Nagatsuka Y; Hirabayashi Y; Kanzaki T
    Br J Dermatol; 2001 Feb; 144(2):363-8. PubMed ID: 11251574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Case of Schindler Disease.
    Castro RG; Pérez AMG; Curto MCR; Álvarez JC; Ferreirós AC; Cuadros AV; Bueno DM; Fernández AJC
    Eur J Case Rep Intern Med; 2019; 6(11):001269. PubMed ID: 31890708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.